<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01232244</url>
  </required_header>
  <id_info>
    <org_study_id>OXMDissek</org_study_id>
    <nct_id>NCT01232244</nct_id>
  </id_info>
  <brief_title>Oxyntomodulin, Mechanisms of Action in Relation to Appetite, Food Intake, Gastric Emptying and Energy Expenditure.</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Gentofte, Copenhagen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Gentofte, Copenhagen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Tiny molecules (hormones) are released from the bowels and other organs to the bloodstream in
      response to meals in order to orchestrate the metabolism. Oxyntomodulin, GLP-1 and glucagon
      are all known to regulate parameters such as appetite, food intake and induce weight loss.

      Therefore we want to investigate mechanistic relations between the three hormones.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">January 2012</completion_date>
  <primary_completion_date type="Actual">January 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Gastric emptying</measure>
    <time_frame>4 h</time_frame>
    <description>Assessed by the acetaminophen - method</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Satiety</measure>
    <time_frame>4 h</time_frame>
    <description>Assessed by VAS</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Hunger</measure>
    <time_frame>4 h</time_frame>
    <description>Assessed by an ad'libitum meal</description>
  </primary_outcome>
  <primary_outcome>
    <measure>basal energy expenditure</measure>
    <time_frame>2 x 30min</time_frame>
    <description>Assessed by indirect calorimetry</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>GLP-1</measure>
    <time_frame>4 h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxyntomodulin</measure>
    <time_frame>4 h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glucagon</measure>
    <time_frame>4 h</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>GIP</measure>
    <time_frame>4 h</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">15</enrollment>
  <condition>Incretin Action</condition>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Healthy young males</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>GLP-1 infusion</intervention_name>
    <description>1 pmol/kg/min</description>
    <arm_group_label>Healthy young males</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Glucagon infusion</intervention_name>
    <description>3ng/kg/min</description>
    <arm_group_label>Healthy young males</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Oxyntomodulin infusion</intervention_name>
    <description>3 pmol/kg/min</description>
    <arm_group_label>Healthy young males</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>GLP-1 and glucagon infusion</intervention_name>
    <description>1 pmol/kg/min 3 ng/kg/min</description>
    <arm_group_label>Healthy young males</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>NaCl 9 g/L infusion</description>
    <arm_group_label>Healthy young males</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy young males
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normal fasting plasma glucose

          -  Normal glucose tolerance

          -  Normal haemoglobin levels

          -  Informed content

        Exclusion Criteria:

          -  Diabetes

          -  Pre diabetes (impaired glucose tolerance or impaired fasting glucose)

          -  1st degree relatives with diabetes

          -  Obesity (BMI &gt; 30)

          -  Inflammatory bowels disease

          -  Bowels surgery

          -  Nephropathy

          -  Liver disease

          -  Medication which cannot be on hold for 24h
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jonatan I Bagger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gentofte University Hospital, University of Copenhagen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gentofte University Hospital</name>
      <address>
        <city>Hellerup</city>
        <zip>2900</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 1, 2010</study_first_submitted>
  <study_first_submitted_qc>November 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 2, 2010</study_first_posted>
  <last_update_submitted>December 9, 2013</last_update_submitted>
  <last_update_submitted_qc>December 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 10, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Gentofte, Copenhagen</investigator_affiliation>
    <investigator_full_name>Jonatan I Bagger</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Incretin hormones</keyword>
  <keyword>Glucagon</keyword>
  <keyword>Satiety</keyword>
  <keyword>Hunger</keyword>
  <keyword>Energy expenditure</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glucagon</mesh_term>
    <mesh_term>Glucagon-Like Peptide 1</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

